| Identification | Back Directory | [Name]
VALINOMYCIN | [CAS]
2001-95-8 | [Synonyms]
nsc122023
valinomicin
-valyl)[qr]
VALINOMYCIN
nsc122023[qr]
valinomicin[qr]
VALINOMYCIN 99%
Valinomycin,90%
Valinomycin,96%
antibioticn-329b
VALINOMYCIN,CRYSTAL
POTASSIUM IONOPHORE I
VALINOMYCIN >94% PURITY
akis(1-methylethyl)-[qr]
VALINOMYCINRESEARCH GRADE
VALINOMYCIN READY MADE SOLUTION
Potassium ionophore I,Valinomycin
CYCLO[-L-VAL-D-HYLVA-D-VAL-L-LAC-]3
VALINOMYCIN, STREPTOMYCES FULVISSIMUS
ValinoMycin, froM StreptoMyces fulvissiMus
CYCLO(LAC-VAL-D-HIV-D-VAL-LAC-VAL-D-HIV-D-VAL-)
aleryl-d-valyl-l-lactoyl-l-valyl-d-alpha-hydroxyisovaleryl-d-valyl-l-lactoyl-l
1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,
14,17,20,23,26,29,32,35-dodecone,12,24,36-trimetyl-3,6,9,15,18,21,27,30,33-non
cyclic(d-alpha-hydroxyisovaleryl-d-valyl-l-lactoyl-l-valyl-d-alpha-hydroxyisov
Cyclo(L-Val-D-HyIva-D-Val-L-Lac-)3: HyIva = α-Hydroxyisovaleric acid, Lac = Lactic acid
Valinomycin,Cyclo(L-Val-D-HyIva-D-Val-L-Lac-)3: HyIva = α-Hydroxyisovaleric acid, Lac = Lactic acid
Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
1Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-
hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
3,6,9,15,18,21,27,30,33-Nonaisopropyl-12,24,36-triMethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone | [EINECS(EC#)]
217-896-6 | [Molecular Formula]
C54H90N6O18 | [MDL Number]
MFCD00005114 | [MOL File]
2001-95-8.mol | [Molecular Weight]
1111.32 |
| Chemical Properties | Back Directory | [Appearance]
white crystalline powder | [Melting point ]
186-190 °C
| [alpha ]
D20 +31.0° (c = 1.6 in benzene) | [Boiling point ]
821.74°C (rough estimate) | [density ]
1.060 | [refractive index ]
1.6400 (estimate) | [Fp ]
87℃ | [storage temp. ]
2-8°C
| [solubility ]
DMSO: ≥10 mg/mL
| [form ]
solid
| [pka]
11.32±0.70(Predicted) | [color ]
white
| [optical activity]
[α]20/D +32±2°, c = 1.6% in benzene | [Water Solubility ]
Soluble in DMSO at 10mg/ml. Insoluble in water | [Merck ]
13,9976 | [BRN ]
78657 | [Stability:]
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. | [EPA Substance Registry System]
Valinomycin (2001-95-8) |
| Hazard Information | Back Directory | [Chemical Properties]
white crystalline powder | [Uses]
antibiotic; LD50 (rat, po) 4 mg/kg | [Uses]
K+-selective ionophoric cyclodepsipeptide; potassium ionophore which uncouples oxidative phosphorylation, induces apoptosis in murine thymocytes, inhibits NGF-induced neuronal differentiation and anta
gonizes ET-induced vasoconstriction. Used as insecticide, nematocide. | [Uses]
Valinomycin is a hydrophobic cyclodepsipeptide with potent antitumor activity. Valinomycin is a highly selective potassium ionophore and this action leads to a diverse range of profound cell membrane effects. More recently, valinomycin has found application as a biosensor to detect to detect potassium efflux. | [Uses]
Valinomycin is a hydrophobic cyclodepsipeptide with potent antitumour activity. Valinomycin is a highly selective potassium ionophore and this action leads to a diverse range of profound cell membrane effects. More recently, valinomycin has found application as a biosensor to detect to detect potassium efflux. | [Definition]
ChEBI: A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in severa
Streptomyces strains. | [Uses]
Insecticide, nematocide, Patterson, Wright, US 3520973 (1970 to Am. Cyanamid). | [General Description]
Shiny crystalline solid. Used as an insecticide and nematocide. Not registered as a pesticide in the U.S. | [Reactivity Profile]
VALINOMYCIN is an amide. Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx). | [Health Hazard]
VALINOMYCIN is highly toxic orally. | [Fire Hazard]
When heated to decomposition, VALINOMYCIN emits toxic fumes of nitrogen oxides. | [Biological Activity]
Selective K + ionophore (K 0.5 values are 48, 73, 75, 93 and 246 mM for K + , Rb + , Cs + , Na + and Li + respectively) that transports K + across biological and artificial lipid membranes. Inhibits Ca 2+ -ATPase activity and induces apoptosis through mitochondrial membrane depolarization, caspase-3 activation and phosphatidylserine translocation in vitro . | [Description]
Valinomycin (2001-95-8) is a selective K+ ionophore capable of transporting potassium ions through lipid membranes.1 Valinomycin can induce apoptosis in cells by causing a rapid loss of mitochondrial membrane potential via potassium efflux.2,3 | [Biochem/physiol Actions]
Valinomycin affects the ion transport behavior of mitochondrial systems. | [in vitro]
valinomycin caused substantial cho cells death within 12 h of treatment. several apoptotic events were identified in valinomycin-treated cho cells, including caspase-3 activation, phosphatidylserine (ps) membrane translocation, and mitochondrial membrane depolarization during the first few hours of treatment. k+ efflux was reduced by elevating extracellular k+ concentrations [2]. | [in vivo]
valinomycin is irritant in the case of eye and skin contact. inhalation of valinomycin can cause breathing disturbances and even loss of conscious. lethal doses (ld50) for mouse and rabbit is 2.5 mg/kg and 5 mg/kg respectively. valinomycin also shows to provoke lots of chronic effects, including damage of the central and peripheral nervous system, eyes, lens and cornea [1]. | [storage]
Store at -20°C | [Purification Methods]
Recrystallise valinomycin from dibutyl ether or Et2O. It is dimorphic: modification A crystallises from n-octane, and modification B crystallises from EtOH/H2O. It is soluble in pet ether, CHCl3, AcOH, BuOAc and Me2CO. [Smith et al. J Am Chem Soc 97 7242 1975, UV, IR and NMR see Brocknmann & Schmidt-Kastner Chem Ber 88 57 1955, Beilstein 27 I 9728. 17 IV 9728.] | [References]
1) Pressman, (1976) Biological applications of ionophores; Annu. Rev. Biochem., 45 501
2) Furlong et al., (1998) Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification; Cell Death Diff., 5 214
3) Inai et al. (1997) Valinomycin induces apoptosis of ascites hepatoma cells (AH-130) in relation to mitochondrial membrane potential; Cell Struc. Funct., 22 555 |
|
|